Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open -Label Phase IIa Trial of the Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma

NCT00503763 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT00503763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00503763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open -Label Phase IIa Trial of the Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma
Lead sponsor
Meir Medical Center
Phase
Phase 2
Overall status
Withdrawn
Start date
September 30, 2007
Completion date
March 31, 2009
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

smoldering multiple myeloma